Literature DB >> 1559416

Diabetic foot care. Financial implications and practice guidelines.

G E Reiber1.   

Abstract

Foot problems are common in the 12 million diagnosed and undiagnosed United States diabetic subjects, and result in extensive hospitalization, disfiguring surgery, lifetime disability, and a diminished quality of life. The unequivocal nature of a lower-extremity amputation makes this the best-defined and monitored of the diabetic foot problems. United States hospital discharge data from 1980 to 1987 indicated that amputation rates increased with advancing age, and were higher in blacks than whites, and men than women. Foot pathology has been reported as the most common complication of diabetes leading to hospitalization. Economic considerations extend beyond direct cost estimates based on numbers of affected individuals, and the cost and duration of patient care. Indirect cost estimates describing lost economic productivity because of related illness, disability, and premature death are needed. Multidisciplinary team approaches to diabetic foot care have reported statistically significant pre-post program reductions in morbidity and cost. Regardless of the care setting and the availability of foot care teams, diabetic foot care guidelines should be viewed by providers as recommended minimum practice levels to be adapted according to the patient's pathology, comorbidity, and abilities. Although guidelines specify minimum acceptable practice levels, they are not intended to set a ceiling on professional excellence.

Entities:  

Mesh:

Year:  1992        PMID: 1559416     DOI: 10.2337/diacare.15.1.s29

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  Science, medicine and the future: healing chronic wounds.

Authors:  K G Harding; H L Morris; G K Patel
Journal:  BMJ       Date:  2002-01-19

Review 2.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

3.  Intraoperative fluorescence vascular angiography: during tibial bypass.

Authors:  Diana Perry; Manish Bharara; David G Armstrong; Joseph Mills
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

4.  Wound inflammatory index: a "proof of concept" study to assess wound healing trajectory.

Authors:  Manish Bharara; Jeffrey Schoess; Aksone Nouvong; David G Armstrong
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

5.  Practice patterns of rural family physicians based on the American Diabetes Association standards of care.

Authors:  R J Zoorob; A G Mainous
Journal:  J Community Health       Date:  1996-06

Review 6.  The cost of diabetic foot problems.

Authors:  J D Ward
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 7.  Diabetes mellitus and the St Vincent Declaration. The economic implications.

Authors:  B Leese
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

8.  Patient-level estimates of the cost of complications in diabetes in a managed-care population.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; E H Wagner
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

9.  The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

Authors:  W Ken Redekop; Joseph McDonnell; Paul Verboom; Kornelia Lovas; Zoltan Kalo
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Cold immersion recovery responses in the diabetic foot with neuropathy.

Authors:  Manish Bharara; Vijay Viswanathan; Jonathan E Cobb
Journal:  Int Wound J       Date:  2008-09-01       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.